Search by Drug Name or NDC
NDC 52670-0551-30 Fludeoxyglucose F 18 240 mCi/mL Details
Fludeoxyglucose F 18 240 mCi/mL
Fludeoxyglucose F 18 is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayo Clinic. The primary component is FLUDEOXYGLUCOSE F-18.
Product Information
| NDC | 52670-0551 |
|---|---|
| Product ID | 52670-551_0bb18b12-7009-cbec-e063-6294a90a7673 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fludeoxyglucose F 18 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fludeoxyglucose F-18 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 240 |
| Active Ingredient Units | mCi/mL |
| Substance Name | FLUDEOXYGLUCOSE F-18 |
| Labeler Name | Mayo Clinic |
| Pharmaceutical Class | Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203612 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 52670-0551-30 (52670055130)
| NDC Package Code | 52670-551-30 |
|---|---|
| Billing NDC | 52670055130 |
| Package | 30 mL in 1 VIAL, MULTI-DOSE (52670-551-30) |
| Marketing Start Date | 2013-08-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |